NextLeap Ventures

Cybord specializes in technologies designed to prevent counterfeit, defective, and malicious electronic components from being used in manufacturing. The company employs artificial intelligence and a comprehensive global database to analyze each electronic component before it is placed in a product. By integrating its system with manufacturing equipment, Cybord provides real-time assessments and traceability for components, combining material inspection and documentation to ensure authenticity and quality. This proactive approach addresses a significant issue in the electronics industry, where counterfeit components account for 5 to 10% of all parts, leading to substantial return merchandise authorizations. By enhancing product quality and securing supply chains, Cybord enables original equipment manufacturers, electronics manufacturing services, and distributors to mitigate risks associated with hardware-cyber threats.

Carrar specializes in manufacturing advanced battery systems for electric vehicles, focusing on enhancing performance and longevity. The company employs a novel thermal management system that utilizes two-phase immersion cooling technology, which allows for precise temperature control throughout the battery pack, ensuring uniform cooling at both the cell and pack levels. This innovative approach significantly improves battery efficiency and performance, effectively tripling the battery's lifespan while also reducing the Total Cost of Ownership for commercial vehicles. Carrar's technology not only boosts the return on investment for passenger cars but also aids in managing the heat generated by onboard electronics, thereby delivering superior thermal management solutions for the electric vehicle market.

CorrActions is a technology company that specializes in a software-based platform designed to enhance human-machine interaction. This platform focuses on detecting, decoding, and transforming human brain signals to minimize errors in real-time. By leveraging artificial intelligence, CorrActions enables machines to better understand human behavior and improve learning efficiency. The applications of this technology span various industries, including aviation, automotive, medical, and technology, aiming to revolutionize the efficiency of both humans and machines through advanced brain-computer interface solutions.

Enzymit is focused on transforming global manufacturing by advancing cell-free bio-production technology, which aims to reduce reliance on scarce resources and enhance sustainability. The company develops novel enzymes using artificial intelligence and deep learning algorithms, enabling the creation of innovative molecular machines that can convert abundant feedstocks into valuable products across various sectors, including pharmaceuticals, cosmetics, food, and materials. By employing small, modular bio-reactors, Enzymit enhances efficiency, reduces costs, and minimizes environmental impact compared to traditional whole-cell bio-production methods. This approach not only fosters resource independence but also allows for greater flexibility in product customization, positioning Enzymit as a competitive alternative to conventional chemical manufacturing.

Cybord specializes in technologies designed to prevent counterfeit, defective, and malicious electronic components from being used in manufacturing. The company employs artificial intelligence and a comprehensive global database to analyze each electronic component before it is placed in a product. By integrating its system with manufacturing equipment, Cybord provides real-time assessments and traceability for components, combining material inspection and documentation to ensure authenticity and quality. This proactive approach addresses a significant issue in the electronics industry, where counterfeit components account for 5 to 10% of all parts, leading to substantial return merchandise authorizations. By enhancing product quality and securing supply chains, Cybord enables original equipment manufacturers, electronics manufacturing services, and distributors to mitigate risks associated with hardware-cyber threats.

ShieldIoT provides cybersecurity solutions focused on securing IoT devices from various security threats and operational risks. The company offers an application and hardware agnostic technology platform that protects Linux-based devices across IoT networks without requiring modifications to the device, application, or network. Its platform includes a centralized security management module, ShieldCenter, and a device-level agent module, ShieldSupervisor. Key offerings encompass device security features such as application sandboxing, resource protection, firewalls, VPN communications, and disk encryption. ShieldIoT also provides fleet monitoring capabilities, which include alerts, security policies, and automatic software updates, as well as threat prevention through early detection of cyber and operational threats by analyzing device traffic and behavior. The company serves various sectors, including smart homes, smart cities, healthcare, transportation, and retail. Founded in 2017, ShieldIoT is headquartered in Tel Aviv, Israel.

NewPhotonics is a developer of advanced photonic technologies, focusing on the design of Photonics Engines and silicon photonics integrated circuits (PICs) to enhance optical communications in data centers. The company's innovative solutions aim to replace traditional complementary metal-oxide-semiconductor (CMOS) technologies with cost-effective and efficient silicon photonics chipsets. This transformation significantly reduces power consumption, improves reliability, and alleviates data rate bottlenecks, particularly for compute and artificial intelligence workloads. By offering all-optics optical communication chips that eliminate the need for digital signal processing and traditional optical front ends, NewPhotonics supports manufacturers in achieving energy savings and reducing material costs. Through its commitment to innovation in the photonics sector, NewPhotonics seeks to advance the capabilities of data transmission within hyper-scale data centers.

TechsoMed is an Israeli medical device company focused on developing ultrasound-based real-time monitoring systems specifically for thermal ablation procedures. This technology addresses the high failure rates associated with these minimally invasive treatments, which are used in various applications, including tumor destruction, heart arrhythmia management, and blood pressure regulation. By providing real-time monitoring and control of tissue destruction, TechsoMed's system enhances the effectiveness of ablation procedures, offering significant benefits to patients, physicians, and insurance companies. The integration of their imaging and analysis unit with standard ultrasound devices allows physicians to better predict the progression of tissue destruction, thereby improving treatment outcomes in a market that has significant growth potential.

DataLoop is an Israeli company founded in 2017, specializing in artificial intelligence products and solutions for data automation. Based in Herzliya, the company focuses on streamlining the preparation of visual data for machine and deep learning applications. Its data management and annotation platform facilitates the creation and deployment of computer vision pipelines, encompassing data labeling, automated data operations, and the integration of human oversight for data validation. By addressing various data challenges, DataLoop enables organizations to enhance their operational efficiency and concentrate on their core business activities while reducing costs associated with data preparation.

HT BioImaging Ltd. specializes in developing innovative medical imaging technology aimed at the early detection of oral cancer. Founded in 2015 and located in Ganei Am, Israel, the company has created the HTOScan, a device that utilizes heat diffusion imaging and artificial intelligence to assess tissue for cancerous characteristics. This technology translates the heat diffusion signals into visual images that indicate the likelihood of cancer, allowing for non-invasive and real-time evaluations at the point of care and in operating rooms. HT BioImaging's approach combines expertise from various fields, including AI, signal analysis, computer vision, and oncology, positioning its platform as a valuable tool for clinicians in community clinics and surgical settings.

Nanofabrica, founded in 2016 and based in Tel Aviv, Israel, specializes in advanced 3D printing technology for precision manufacturing. The company focuses on micro and nanomanufacturing, providing solutions for sectors such as robotics, semiconductors, optics, and medical devices. Its innovative Micro Adaptive Projection technology allows for the production of ultra-precise parts with micron-resolution, enabling the creation of complex designs at competitive prices. By integrating semiconductor lithography and advanced optics within its 3D printing processes, Nanofabrica offers a unique capability to meet the demands of mass customization and rapid production. The company actively seeks customer feedback to refine its technology and tackle new challenges, positioning itself as a leader in the evolving landscape of additive manufacturing.

Concertio Inc. specializes in artificial intelligence-driven system performance optimization software, enabling enterprises to enhance computing efficiency while minimizing infrastructure costs. Founded in 2016 and headquartered in New York, the company offers the Concertio Optimizer, which continuously monitors the interactions between applications and systems, automating parameter tuning throughout development and deployment. Its tools, including Optimizer Studio and Optimizer Runtime, cater to performance engineers and IT professionals by providing an optimization toolkit and a dynamic optimization framework that improve the performance of systems and components in real-time. Concertio's solutions are utilized by prominent industry players such as Intel and Marvell, transforming general-purpose systems into specialized, high-performance configurations tailored to specific workloads.

Geneyx is a biotechnology company focused on improving genetic analysis and promoting precision medicine through innovative technologies. By collaborating with physicians and hospital laboratories globally, Geneyx aims to address the challenges of undiagnosed and untreated diseases. The company has developed an artificial intelligence-based analytics platform that enhances the interpretation of genomic data, providing clinicians with accurate and rapid diagnoses. This platform allows for an end-to-end approach to secure genetic data, significantly increasing diagnostic yield and reducing turnaround times to mere minutes. Through its efforts, Geneyx seeks to empower the healthcare community with advanced tools that support drug discovery and the development of novel therapeutics.

DataLoop is an Israeli company founded in 2017, specializing in artificial intelligence products and solutions for data automation. Based in Herzliya, the company focuses on streamlining the preparation of visual data for machine and deep learning applications. Its data management and annotation platform facilitates the creation and deployment of computer vision pipelines, encompassing data labeling, automated data operations, and the integration of human oversight for data validation. By addressing various data challenges, DataLoop enables organizations to enhance their operational efficiency and concentrate on their core business activities while reducing costs associated with data preparation.

Concertio Inc. specializes in artificial intelligence-driven system performance optimization software, enabling enterprises to enhance computing efficiency while minimizing infrastructure costs. Founded in 2016 and headquartered in New York, the company offers the Concertio Optimizer, which continuously monitors the interactions between applications and systems, automating parameter tuning throughout development and deployment. Its tools, including Optimizer Studio and Optimizer Runtime, cater to performance engineers and IT professionals by providing an optimization toolkit and a dynamic optimization framework that improve the performance of systems and components in real-time. Concertio's solutions are utilized by prominent industry players such as Intel and Marvell, transforming general-purpose systems into specialized, high-performance configurations tailored to specific workloads.

GuardKnox is an automotive technology company specializing in high-performance, secure, and customizable products for driver-centric mobility. Established in 2016 and headquartered in Israel, with additional locations in Munich, Germany, and Detroit, Michigan, GuardKnox focuses on developing scalable technologies for software-defined vehicles. The company's platform enhances vehicle connectivity and allows consumers to customize both performance and in-vehicle experiences. By offering secure design and high-speed firmware, GuardKnox enables clients to create applications and services efficiently, reducing time to market while maintaining cost-effectiveness.

TechsoMed is an Israeli medical device company focused on developing ultrasound-based real-time monitoring systems specifically for thermal ablation procedures. This technology addresses the high failure rates associated with these minimally invasive treatments, which are used in various applications, including tumor destruction, heart arrhythmia management, and blood pressure regulation. By providing real-time monitoring and control of tissue destruction, TechsoMed's system enhances the effectiveness of ablation procedures, offering significant benefits to patients, physicians, and insurance companies. The integration of their imaging and analysis unit with standard ultrasound devices allows physicians to better predict the progression of tissue destruction, thereby improving treatment outcomes in a market that has significant growth potential.

Magentiq Eye Ltd. is a medical device company based in Haifa, Israel, established in 2014. It specializes in developing advanced technologies for endoscopic procedures, particularly focusing on automatic polyp detection during colonoscopies. The company's flagship product, the Automatic Polyp Detection System (APDS), leverages deep learning and computer vision to enhance the accuracy of polyp identification, thereby reducing the miss rate during examinations. The APDS is available in two formats: APDS-RT, which operates in real-time by processing video feeds from endoscopic cameras, and APDS-OFL, which analyzes pre-recorded colonoscopy videos. Given the prevalence of colonoscopies—approximately 40 million performed annually—the system aims to improve patient outcomes by increasing detection rates and minimizing the risk of interval cancers. Magentiq Eye's technology not only supports physicians in making more informed decisions during procedures but also has the potential for integration with existing endoscopic equipment or as a service model for clinics and hospitals.

Sanolla is a digital healthcare platform focused on creating innovative medical diagnostic solutions for healthcare professionals and patients. The company specializes in AI-powered diagnostic equipment that analyzes previously inaccessible body infrasounds and vital signs, facilitating the early assessment and monitoring of cardiopulmonary conditions. Sanolla's products are designed to be affordable and user-friendly, promoting non-invasive assessments that enable immediate and accurate diagnostic results. This approach not only enhances patient convenience by reducing unnecessary clinic visits but also minimizes the associated risks of exposure to infections, ultimately saving time and healthcare costs.